Medicare Advantage Cost-Cutting Rule Could Impact Care
by Eleanor Laise, Senior Editor, Kiplinger's Retirement Report
Feb 27, 2019
2 minutes
A new rule designed to drive down prices of physician-administered drugs may jeopardize Medicare Advantage enrollees' access to needed care, patient advocates say.
Starting this year, the Centers for Medicare and Medicaid Services is allowing Advantage plans to implement "step therapy" for drugs covered under Part B, which include many treatments for cancer and other serious conditions. That means the plans can require patients
You’re reading a preview, subscribe to read more.
Start your free 30 days